Clinical Trial Update: Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of mesenchymal stem cells on vertebral bone defects caused by spinal tuberculosis, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Tuberculosis

Drugs mentioned

• Mesenchymal Stem Cell (mesenchymal stem cell)

Snippet

Sponsor: Ahmad Jabir Rahyussalim | Conditions: Spinal Tuberculosis, Mesenchymal Stem Cell | Phase 2 | Status: UNKNOWN